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a  b  s  t  r  a  c  t
Shewanella putrefaciens rarely causes infection in humans. In the last few decades a growing
number  of cases have been described. The following report outlines the case of a 40-year-
old  immunocompetent white man with S. putrefaciens infective endocarditis. This is the
ﬁrst  known case of infective endocarditis due to an apparently monomicrobial S. putrefa-
ciens  infection, and the second known case of S. putrefaciens-related infective endocarditisKeywords:
Shewanella
Endocarditis
Bacteremia
worldwide.
with  a burn at the medial region of his right thigh, which was
© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Shewanella spp. encompass a group of saprophytic Gram-
negative oxidative bacilli generally present in warm climates
as  part of marine microﬂora.1 Other possible sources include
aquatic  reservoirs, oil and gas reserves, as well as soil, snake
bites,  ﬁsh, poultry, dairy and beef products.2 Although appar-
ently  abundant in the environment, human infection with
these  pathogens is relatively rare. When identiﬁed in human
isolates,  it usually presents as a mixed bacterial ﬂora.2 Of the
Shewanella  spp., human clinical infections are caused by She-
wanella  algae and Shewanella putrefaciens, the greater share of
which  being the more  pathogenic S. algae, possibly due to its
ability  to carry out beta-hemolytic type reactions and exo-
toxin  production.2 The most common clinical manifestations
are  skin and soft tissue infection, bacteremia and otitis.3,4Shewanella spp. have also been associated with abdominal,
joint  and bone, pulmonary, urinary, ophthalmic, and cere-
bral  infection.1,4 Bacteremia is often present but the course is
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1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licençausually benign.1,4 There is only one known case of polymi-
crobial infective endocarditis related to S. putrefaciens.5 The
following  report outlines the ﬁrst known case of infec-
tive  endocarditis due to an apparently monomicrobial S.
putrefaciens  infection, and the second known case of S.
putrefaciens-related infective endocarditis worldwide.
Case  report
A 40-year-old immunocompetent man  presented to his vas-
cular  surgeon with complaints of right hand swelling, calor,
numbness,  and pain. An upper extremity venous doppler
showed thrombosis of the right radial vein. He was  admitted
to  the hospital and started on anticoagulation therapy with
heparin.  Two weeks prior to admission the patient presentednal Healthcare, 250 Stanaford Road, Beckley, WV 25801, USA.
evaluated  by his primary care physician and topical antibiotics
were  prescribed. He had also been complaining of shaking
chills  for several days prior to admission. Past medical his-
 de CC BY-NC-ND
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ory was  signiﬁcant for seizure disorder, dyslipidemia, tobacco
se,  asthma, bronchitis, sleep apnea, hypertension, hypothy-
oidism,  osteoarthritis, right carpal tunnel release surgery, and
enous  insufﬁciency. Physical examination revealed a 4/5 sys-
olic heart murmur over mitral valve area, a 7 cm× 5 cm ulcer
ver  medial region of the thigh with surrounding erythema
econdary to burn and edema, erythema and calor involving
he  right thumb extending into the wrist.
On hospital day (HD) 2, the patient started having inter-
ittent fever (every 48 h) up to 103.5 ◦F with shaking chills.
lood  cultures were  obtained; however, no antibiotics were  ini-
ially  prescribed as no clear infectious source was  identiﬁed.
n  HD 7, a venogram of right upper extremity showed reso-
ution  of the venous thrombosis. Cefazolin 1 g intravenously
very 8 h was  empirically started on the same day for persis-
ent  fever. He was  noted to have an elevated procalcitonin level
40  ng/mL), C-reactive protein (7.1 mg/dL), erythrocyte sedi-
entation  rate (65 mm/h) and rheumatoid factor (15.5 IU/mL).
hite  blood cell counts were  within normal limits. On
D  8, right hand erythema and pain symptoms worsened,
arranting repeated ultrasound evaluation of right upper
xtremity,  which revealed the presence of thrombus in the dis-
al radial artery. The persistent fever, the presence of systolic
urmur,  and thrombo-embolic phenomenon involving the
adial  artery led to investigation of possible endocarditis with
ransesophageal echocardiography revealing a 1.6 cm× 1.0 cm
egetation  in the posterior mitral valve leaﬂet with hypoechoic
reas  suggestive of valvular abscess. Antibiotic was  changed to
efepime 2 g intravenously every 12 h and Gentamicin 120 mg
ntravenously every 8 h for the treatment of endocarditis. Two
ets  of blood cultures (each with aerobic and anaerobic bot-
les)  were  taken throughout the hospital stay on HDs 4, 7
nd  12. Eventual growth of Gram-negative bacilli was  detected
n  all six sets of blood cultures [BacT/ALERT blood culture
ystem  (bioMérieux, Durham, NC)]. The Gram-negative bacilli
ere  identiﬁed by VITEK 2 automated system (bioMérieux,
urham, NC), as S. putrefaciens with 99.9% probability. Patient
as  transferred to a tertiary care center and had a valvectomy
f  the posterior leaﬂet of mitral valve. Pathology of mitral valve
eaﬂet  showed granulation tissue with acute ﬁbrinous inﬂam-
ation.  The valve cultures were  negative. Subsequently, the
atient  was  lost to follow-up.
iscussion
espite the vast prevalence of Shewanella spp. in the envi-
onment,  they are rarely implicated in clinical scenarios
s  a source of pathogenicity.4 Two species of Shewanella (S.
lgae  and S. putrefaciens) are known to occasionally cause
nfection in humans. Khashe et al.2 reported that certain
henotypic characteristics could be useful to differentiate S.
utrefaciens from S. algae. Compared to S. algae, S. putrefaciens
s  nonhemolytic on sheep blood agar, unable to grow at 42 ◦C
r  on high salt media (6.5%), but able to produce acid from
rabinose, maltose, and sucrose.2 Automated identiﬁcation
ystems have been reported as not being able to distinguish
.  algae from S. putrefaciens reliably, as S. algae has not been
pdated  in the databases.1 Khashe and Janda2 tested ﬁve
trains  of S. algae and ﬁve strains of S. putrefaciens on different
24;1 8(6):686–688  687
bacterial identiﬁcation systems that included API 20E, API
NFT,  RapID NF Plus and the automated VITEK system. All of
these  identiﬁcation systems misidentiﬁed S. algae as S. putre-
faciens.  However, manual reading of arabinose and maltose
reaction  permitted the distinction between S. algae and S.
putrefaciens.  Despite the utility of the production of acid from
carbohydrate oxidation for the correct identiﬁcation of S.
algae,  S. putrefaciens can produce varied results which have led
to the recommendations of performing 16S rRNA sequencing
for  the correct speciation of Shewanella spp.3 In our case, the
identiﬁcation of the microorganism was performed through
VITEK  2 system. The new VITEK 2 system has now included
in  its database S. algae and theoretically it could be detected
on  clinical samples. As the accuracy of the identiﬁcation of
S.  algae on the VITEK 2 system, to our knowledge, has not
been  reported, it is possible that this strain could have been
misidentiﬁed as S. putrefaciens instead of S. algae.
S.  putrefaciens, when detected, is often a component of
polymicrobial infections.4 This type of presentation has made
it  difﬁcult to determine the signiﬁcance of S. putrefaciens as
an  isolated pathogen. However, S. putrefaciens monomicrobial
infections have been reported, conﬁrming the pathogenicity
of  this microorganism. Vignier et al.4 reported that half of
their  cases of Shewanella infection were monomicrobial. In
their  review of the literature, they determined that a skin or
mucosal  portal of entry was  found in 53% of the reported She-
wanella  infection cases. These were  often preceded by chronic
ulceration  of the lower limb, trauma, burn wound, or seawater
exposure.  In our patient, the source of S. putrefaciens was  not
identiﬁed.  Nonetheless, it is reasonable to assume that the
patient’s  burn wound was the port of entry. Unfortunately, no
cultures of the burn wound on the patient’s right lower limb
were  obtained.
Dhawan et al.5 described a case of S. putrefaciens and
viridans group streptococci polymicrobial mitral valve endo-
carditis  in a patient with known rheumatic heart disease.
Compared to our case, only one microorganism was  isolated
validating the pathogenic role of S. putrefaciens. Six sets of
blood  cultures, in a period of 9 days, turned out positive for
S.  putrefaciens resulting in the conﬁrmation of monomicrobial
infection due to S. putrefaciens. This rare case of monomicrobial
infective endocarditis by S. putrefaciens in an immunocom-
petent host adds to the current literature of the increased
numbers of human infection associated with the organism
and  highlights the pathogenic role of Shewanella spp.
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